The Company decided to write off all property, plant, and equipment (gross $66,242; net already $0 due to prior impairment) as of April 30, 2026, citing no further economic benefit, and subsequently decided to write off its entire patent and trademark (gross $35,285; net $0) on the same basis, leaving total assets of only $16,555 (mostly prepayments).
The Company continued to generate zero revenue and had no operating activity for the quarter; the $19,062 net loss (vs. $11,146 in the prior-year quarter) was driven entirely by $18,021 in general and administrative expenses (professional fees and foreign-exchange loss), with no cost of revenue or selling/marketing spend.
Going-concern substantial doubt persists: cash was $55, current liabilities exceeded current assets by $784,514, and the company remains wholly dependent on a $511,354 director loan and $148,322 in third-party loans; the filing reiterates that principal wellness-and-beauty operations are still only 'planned,' with no outlets, franchisees generating revenue, or product distribution in place.
Management concluded disclosure controls and procedures were not effective as of April 30, 2026 due to material weaknesses in segregation of duties and insufficient written US GAAP/SEC accounting policies; no changes in internal control over financial reporting occurred during the quarter, and no legal proceedings, unregistered equity sales, or subsequent events requiring recognition were disclosed.
(Filed on March 16, 2026)
—
—
$55
The company generated zero revenue for the three and six months ended January 31, 2026, consistent with prior periods; both reportable segments (investment holding and wellness and beauty services) and all three geographic segments (Nevada, Seychelles, Hong Kong) reported no revenue, and the company disclosed no new partnerships, operational milestones, or changes to its stated wellness-and-beauty-services business plan.
All long-lived assets remain fully impaired with net carrying values of $0: property, plant and equipment (cost $66,246, fully offset by $25,014 accumulated depreciation and $41,232 impairment) and patent/trademark (cost $35,285, fully offset by $6,240 amortization and $29,045 impairment). Cash and equivalents stood at only $55 at January 31, 2026, and the company carries a $753,614 current-asset deficit, $2,607,950 accumulated deficit, and a going-concern qualification noting dependence on continuing shareholder and director financial support.
Operations were funded entirely by related-party and third-party loans: director Niu Yen-Yen's loan increased to $484,543 (a $39,542 increase over the six months, including $33,407 of new borrowings reflected in cash flows), and the unsecured loan from Shang Hai Shi Ba Enterprise Management Centre rose to $145,272. No external credit facilities exist.
Management concluded that disclosure controls and procedures were not effective as of January 31, 2026, citing two material weaknesses: inadequate segregation of duties and effective risk assessment, and insufficient written policies and procedures for accounting and financial reporting under US GAAP and SEC guidelines. No changes to internal control over financial reporting were reported during the quarter.
(Filed on December 11, 2025)
—
—
$55
Vanguard Green Investment remained in a pre-revenue, non-operating state for the three months ended October 31, 2025: zero revenue, zero property, plant and equipment (carrying value reduced to $0 via impairment), and zero patent/trademark value (fully impaired). The company's planned wellness and beauty services business in China, with stated but non-binding intentions to expand to Singapore, Malaysia, Hong Kong, and the Middle East, produced no operational activity, and no concrete milestones, partnerships, or outlet openings were announced.
The filing carried a substantial-doubt going-concern qualification: cash and cash equivalents were $55, total assets $10,165, current liabilities exceeded current assets by $713,042, and the accumulated deficit reached $2,577,818. Quarterly operating cash outflow of $7,687 was offset almost entirely by a $7,649 loan from director Niu Yen-Yen (total outstanding director loan $455,152, unsecured and interest-free) and a small draw on an unsecured third-party loan from Shang Hai Shi Ba Enterprise Management Centre (total $141,442, repayment extended to 2026-2027).
Management concluded disclosure controls and procedures were not effective as of October 31, 2025 due to material weaknesses in segregation of duties and in written accounting/financial-reporting policies; no changes to internal control were reported during the quarter. No legal proceedings, unregistered equity sales, or subsequent events requiring recognition or disclosure were identified.
(Filed on October 24, 2025)
—
—
$93
Annual context (fiscal year ended July 31, 2025; no Q4-specific operating data is provided in this 10-K): Vanguard generated zero revenue, incurred no cost of revenue or selling expenses, and employed 2 people. Total assets were $15,258 (cash $93); all property, plant and equipment and patent/trademark intangibles were fully written off to $0. Net loss for the full year was $76,778, down from $85,697 in the prior year, driven primarily by lower general and administrative expenses ($65,920 vs. $105,641) partially offset by $10,863 in finance costs.
The filing discloses a stated intent to pivot from its wellness and beauty-services model to green finance and ESG-related activities, including carbon trading, carbon pledge financing, and carbon custody. This is presented as a forward-looking business direction; the filing provides no evidence of completed transactions, client relationships, or revenue activity in the green-finance space during FY2025.
Auditor JP Centurion & Partners raised substantial doubt about the company's ability to continue as a going concern. Annual figures as of July 31, 2025: working-capital deficiency of $689,654, accumulated deficit of $2,560,821, capital deficiency of $724,578, and negative operating cash flow of $74,051. Liquidity is dependent on unsecured, interest-free loans from director Niu Yen-Yen ($445,001 current) and a third-party lender ($138,656 combined current and non-current).
The sole China operating subsidiary, MU Global Health Management (Shanghai) Limited, was disposed on July 30, 2024 (prior fiscal year) for $11,975, leaving the Nevada parent and its Seychelles and Hong Kong subsidiaries as holding vehicles with no active operating business. No new operational entities, partnerships, or franchisee deployments were reported for FY2025. Management also concluded that internal controls over financial reporting were not effective as of July 31, 2025, citing a material weakness in segregation of duties, with remediation planned but not yet completed.
